ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Tract Infections

COVID-19 trials near Berlin, BE, DEU:

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...

Enrolling
COVID-19
Bacterial Pneumonia
Drug: Placebo (human albumin 1%)
Drug: Trimodulin

Phase 3

Biotest

Berlin, Germany and 58 other locations

The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need t...

Active, not recruiting
COVID-19
SARS CoV 2 Infection
Drug: Bemnifosbuvir (BEM)
Drug: Placebo

Phase 3

Atea Pharmaceuticals
Atea Pharmaceuticals

Berlin, Germany and 263 other locations

antibodies and a history of SARS-CoV-2 vaccination or previous COVID-19 disease at least 90 days prior to planned trial vaccination....

Active, not recruiting
COVID-19 Disease
Biological: ABNCoV2 50ug
Biological: ABNCoV2 100ug

Phase 2

Bavarian Nordic
Bavarian Nordic

Berlin, Germany and 1 other location

Objective of the study is to assess the safety and efficacy of CO2 removal by the multiECCO2R (CO2 Removal System) on the multiFiltrate/multiFiltrate...

Enrolling
Covid19
Hypercapnia
Device: multiECCO2R blood-gas exchanger
Fresenius Medical Care (FMC)

Berlin, Germany and 5 other locations

with extracorporeal blood oxygenation (ECMO) during their acute COVID-19 infection.The study drug acts by neutralizing functional a...

Active, not recruiting
Long Covid
Drug: BC 007 or matching placebo

Phase 2

Berlin Cures

Berlin, Germany and 15 other locations

The goal of this clinical trial is to evaluate the therapeutic value of an approved drug (Vericiguat) in patients with post-COVID-19...

Not yet enrolling
Post-COVID ME/CFS
Drug: Vericiguat Oral Tablet

Phase 2

Charité University Medicine Berlin
Charité University Medicine Berlin

Berlin, Germany

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...

Enrolling
Sickle Cell Disease (SCD)
Drug: Crizanlizumab

Phase 2

Novartis
Novartis

Berlin, Germany and 56 other locations

The main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A i...

Active, not recruiting
Hemophilia A
Drug: BAX 888

Phase 1, Phase 2

Baxalta
Baxalta

Berlin, Germany and 27 other locations

This trial has two parts. Part A and Part B. Due to changes in the overall clinical development plan, Part B will no longer be conducted. The objecti...

Active, not recruiting
Protection Against COVID-19 and Infections With SARS CoV 2
Vaccine Adverse Reaction
Biological: BNT162b1
Biological: BNT162b2

Phase 1, Phase 2

BioNTech
BioNTech

Berlin, Germany and 4 other locations

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Placebo
Drug: Tozorakimab

Phase 3

AstraZeneca
AstraZeneca

Berlin, Germany and 380 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems